PICTET ASSET MANAGEMENT LTD - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 116 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
PICTET ASSET MANAGEMENT LTD ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$3,951,000
+73.0%
440,467
+6.6%
0.02%
+66.7%
Q2 2016$2,284,000
+178.2%
413,067
+74.0%
0.01%
+125.0%
Q1 2016$821,000
-33.5%
237,4000.0%0.00%
-20.0%
Q4 2015$1,235,000
-42.2%
237,400
-32.7%
0.01%
-44.4%
Q3 2015$2,136,000
-55.7%
353,000
+4.2%
0.01%
-55.0%
Q2 2015$4,823,000
+28.6%
338,700
-5.0%
0.02%
+17.6%
Q4 2014$3,750,000
+10.6%
356,500
+0.8%
0.02%
+6.2%
Q3 2014$3,390,000353,5000.02%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2016
NameSharesValueWeighting ↓
SV Health Investors, LLC 888,132$4,618,0003.71%
GREAT POINT PARTNERS LLC 1,282,527$6,669,0002.80%
Broadfin Capital, LLC 2,412,995$12,548,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 685,000$3,562,0000.52%
GLOBEFLEX CAPITAL L P 209,787$1,091,0000.29%
TFS CAPITAL LLC 477,884$2,485,0000.27%
FT Options LLC 127,400$220,0000.16%
Tourbillon Capital Partners, L.P. 1,264,999$6,578,0000.15%
Birchview Capital, LP 40,000$208,0000.12%
SECOR Capital Advisors, LP 70,111$365,0000.10%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders